title: A new method for isolation of interstitial fluid from human solid tumors applied to proteomic analysis of ovarian carcinoma tissue.
abstract: Major efforts have been invested in the identification of cancer biomarkers in plasma, but the extraordinary dynamic range in protein composition, and the dilution of disease specific proteins make discovery in plasma challenging. Focus is shifting towards using proximal fluids for biomarker discovery, but methods to verify the isolated sample's origin are missing. We therefore aimed to develop a technique to search for potential candidate proteins in the proximal proteome, i.e. in the tumor interstitial fluid, since the biomarkers are likely to be excreted or derive from the tumor microenvironment. Since tumor interstitial fluid is not readily accessible, we applied a centrifugation method developed in experimental animals and asked whether interstitial fluid from human tissue could be isolated, using ovarian carcinoma as a model. Exposure of extirpated tissue to 106 g enabled tumor fluid isolation. The fluid was verified as interstitial by an isolated fluid:plasma ratio not significantly different from 1.0 for both creatinine and Na(+), two substances predominantly present in interstitial fluid. The isolated fluid had a colloid osmotic pressure 79% of that in plasma, suggesting that there was some sieving of proteins at the capillary wall. Using a proteomic approach we detected 769 proteins in the isolated interstitial fluid, sixfold higher than in patient plasma. We conclude that the isolated fluid represents undiluted interstitial fluid and thus a subproteome with high concentration of locally secreted proteins that may be detected in plasma for diagnostic, therapeutic and prognostic monitoring by targeted methods.
authors.affiliation: Department of Biomedicine, University of Bergen, Bergen, Norway.
authors.forename: Hanne
authors.initials: H
authors.lastname: Haslene-Hox
authors.forename: Eystein
authors.initials: E
authors.lastname: Oveland
authors.forename: Kaja C
authors.initials: KC
authors.lastname: Berg
authors.forename: Odd
authors.initials: O
authors.lastname: Kolmannskog
authors.forename: Kathrine
authors.initials: K
authors.lastname: Woie
authors.forename: Helga B
authors.initials: HB
authors.lastname: Salvesen
authors.forename: Olav
authors.initials: O
authors.lastname: Tenstad
authors.forename: Helge
authors.initials: H
authors.lastname: Wiig
mesh_terms: D001201:Ascites / Q000378:metabolism; D014408:Biomarkers, Tumor / Q000378:metabolism; D002498:Centrifugation / Q000379:methods*; D002850:Chromatography, Gel; D002851:Chromatography, High Pressure Liquid; D003102:Colloids; D003404:Creatinine / Q000378:metabolism; D045604:Extracellular Fluid / Q000378:metabolism*; D005110:Extracellular Space / Q000378:metabolism; D005260:Female; D006801:Humans; D042541:Intracellular Space / Q000378:metabolism; D009363:Neoplasm Proteins / Q000378:metabolism; D009997:Osmotic Pressure; D010051:Ovarian Neoplasms / Q000097:blood / Q000378:metabolism*; D020543:Proteome / Q000378:metabolism; D040901:Proteomics / Q000379:methods*; D015203:Reproducibility of Results
chemical_list: D014408:Biomarkers, Tumor; D003102:Colloids; D009363:Neoplasm Proteins; D020543:Proteome; D003404:Creatinine